Back
 JBM  Vol.7 No.8 , August 2019
Evaluation of the Permeation and Penetration of Two Formulations of Terbinafine Chlorhydrate Incorporated in Liposomes (Cream 1%) vs. a Conventional Formulation (Cream 1%), in an in Vitro-ex Vivo Model
Abstract: In this trial, a topical formulation of a 1% liposome TH cream was compared to a conventional TH formulation. Permeation was evaluated through a synthetic membrane. The study provided information on the rate of diffusion and percentage of drug release and also compared the penetration dynamics in the layers of the stratum corneum of both formulations. Liposome TH cream was able to deliver the active ingredient to a larger number of SC layers, with a higher amount of drug, which is very promising for the treatment of superficial mycoses.
Cite this paper: Kinski, S. , Antonieta, A. , Nicolas, C. and Alfredo, I. (2019) Evaluation of the Permeation and Penetration of Two Formulations of Terbinafine Chlorhydrate Incorporated in Liposomes (Cream 1%) vs. a Conventional Formulation (Cream 1%), in an in Vitro-ex Vivo Model. Journal of Biosciences and Medicines, 7, 119-133. doi: 10.4236/jbm.2019.78010.
References

[1]   Balfour, J.A. and Faulds, D. (1992) Terbinafine. A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Superficial Mycoses. Drugs, 43, 259-284.
https://doi.org/10.2165/00003495-199243020-00010

[2]   McClellan, K.J., Wiseman, L.R. and Markham, A. (1999) Terbinafine. An Update of Its Use in Superficial Mycoses. Drugs, 58, 179-202.
https://doi.org/10.2165/00003495-199958010-00018

[3]   Eman, A., et al. (2016) Skin Models for the Testing of Transdermal Drugs. Clinical Pharmacology, 8, 163-176.
https://doi.org/10.2147/CPAA.S64788

[4]   Year (2000) The Sanford Guide to Antimicrobial Therapy. 13th Edition, 75 p..

[5]   Soares, M.M.S.R. and Cury, A.E. (2001) In Vitro Activity of Antifungal and Antiseptic Agents against Dermatophyte Isolates from Patients with Tinea Pedis. Brazilian Journal of Microbiology, 32, 130-134.
https://doi.org/10.1590/S1517-83822001000200012

[6]   Gaba, B., et al. (2015) Nanostructured Lipid Carrier System for Topical Delivery of Terbinafine Hydrochloride. Bulletin of Faculty of Pharmacy, Cairo University, 53, 147-159.
https://doi.org/10.1016/j.bfopcu.2015.10.001

[7]   Barry, B.W. (1983) Dermatological Formulations: Percutaneous Absorption. Journal Pharmaceutical Sciences, 73, 479.
https://onlinelibrary.wiley.com/doi/abs/10.1002/jps.2600730442

[8]   Rico, C.I., et al. (2013) Skin Permeation and Biodistribution of a Phthalocyanine Nanoemulsion of Chlorinated Aluminum (PcAlCl) Applied Topically in Wistar Rats. Argentine Journal of Dermatology, 94, 28.
https://rad-online.org.ar/2013/07/01/permeacion-en-piel-y-biodistribucion-de-una-nanoemulsion-de-ftalocianina-de-aluminio-clorada-pcalcl-aplicada-topicamente-en-ratas-wistar

[9]   Nava, G., et al. (2011) Formulation and in Vitro, ex Vivo and in Vivo Evaluation of Elastic Liposomes for Transdermal Delivery of Ketorolac Tromethamine. Pharmaceutics, 3, 954-970.
https://doi.org/10.3390/pharmaceutics3040954
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857066/pdf/pharmaceutics-03-00954.pdf

[10]   Lampe, M.A., et al. (1983) Human Stratum Corneum Lipids: Characterization and Regional Variations. Journal of Lipid Research, 24, 120-130.
http://www.jlr.org/content/24/2/120.full.pdf

[11]   Jacobi, U., Taube, H., Schäfer, U.F., Sterry, W. and Lademann, J. (2005) Comparison of Four Different in Vitro Systems to Study the Reservoir Capacity of the Stratum Corneum. Journal of Controlled Release, 103, 61-71.
https://doi.org/10.1016/j.jconrel.2004.11.013

[12]   Escribano, E., Calpena, A.C., Queralt, J., Obach, R. and Doménech, J. (2003) Assessment of Diclofenac Permeation with Different Formulations: Anti-Inflammatory Study of a Selected Formula. European Journal of Pharmaceutical Sciences, 19, 203-210.
https://doi.org/10.1016/S0928-0987(03)00103-9

[13]   Mukherjee, B., et al. (2005) A Comparison between Povidone-ethylcellulose and Povidone-Eudragit Transdermal Dexamethasone Matrix Patches Based on in Vitro Skin Permeation. European Journal of Pharmaceutics and Biopharmaceutics, 59, 475-483.
https://doi.org/10.1016/j.ejpb.2004.09.009

[14]   Heike, W., Kostka, K.-H., Lehr, C.-M. and Schaefer, U.F. (2000) Drug Distribution in Human Skin Using Two Different in Vitro Test Systems: Comparison with in Vivo Data. Pharmaceutical Research, 17, 1475-1481.
https://doi.org/10.1023/A:1007648807195

[15]   Lademann, J., Jacobi, U., Surber, C., Weigmann, H.-J. and Fluhrc, J.W. (2009) The Tape Stripping Procedure—Evaluation of Some Critical Parameters. European Journal of Pharmaceutics and Biopharmaceutics, 72, 317-323.
https://doi.org/10.1016/j.ejpb.2008.08.008

[16]   Escoar-Chávez, J.J., et al. (2008) The Tape-Stripping Technique as a Method for Drug Quantification in Skin. Journal of Pharmacy & Pharmaceutical Sciences, 11, 104-130.
https://doi.org/10.18433/J3201Z

[17]   Franz, T.J., Lehman, P.A. and Raney, S.G. (2009) Use of Excised Human Skin to Assess the Bioequivalence of Topical Products. Skin Pharmacology and Physiology, 22, 276-286.
https://doi.org/10.1159/000235828

[18]   Meyer, W., et al. (1978) The Skin of Domestic Mammals as a Model for the Human Skin, with Special Reference to the Domesticpig. Current Problems in Dermatology, 7, 39-52.
https://doi.org/10.1159/000401274

[19]   Schmook, F.P., et al. (2001) Comparison of Human Skin or Epidermis Models with Human and Animal Skin in in-Vitro Percutaneus Absorption. International Journal of Pharmaceutics, 215, 51-56.
https://doi.org/10.1016/S0378-5173(00)00665-7

[20]   Sekkat, N., et al. (2004) Porcineear Skin as a Model for the Assessment of Transdermal Drug Delivery to Prematureneonates. Pharmaceutical Research, 21, 1390-1397.
https://doi.org/10.1023/B:PHAM.0000036912.94452.d0

[21]   Debandi, M.V., et al. (2011) Evaluation of Different Membranes for in Vitro Release of Anticellulitic Actives. Advances in Science and Engineering, 2, 97-105.

[22]   Villarino, N.F., et al. (2006) Transdermal Drug Administration: A Therapeutical Alternative. Analecta Veterinaria, 26, 28-37.
http://sedici.unlp.edu.ar/bitstream/handle/10915/11189/Documento_completo.pdf?sequence=1

[23]   Walters, K.A. (2002) Dermatological and Transdermical Formulations. Drugs and the Pharmaceutical Sciences. CRC Press, Boca Raton, Vol. 119, 89-115.

[24]   Souto, E.B. and Muller, R.H. (2006) Investigation of the Factors Influencing the Incorporation of Clotrimazole in SLN and NLC Prepared by Hot High Pressure Homogenization. Journal of Microencapsulation, 23, 377-388.
https://doi.org/10.1080/02652040500435295

[25]   Chen, Y., et al. (2012) Development of Terbinafine Solid Lipid Nanoparticles as Tropical Delivery System. International Journal of Nanomedicine, 7, 4409-4418.
https://doi.org/10.2147/IJN.S33682

[26]   Nair, A., et al. (2013) Basic Considerations in the Dermatokinetics of Topical Formulations. Brazilian Journal of Pharmaceutical Sciences, 49, 423-434.
https://doi.org/10.1590/S1984-82502013000300004

[27]   Ozcan, I., et al. (2009) Enhanced Tropical Delivery of Terbinafine Hydrochloride with Chitosan Hydrogels. PharmSciTech, 10, 1024-1031.
https://doi.org/10.1208/s12249-009-9299-x

[28]   Otarola, J.J., Lassalle, V., Fernández Band, B.S. and Garrido, M. (2012) Drug Carrier Systems Based on Nanostructured Lipid Carriers for Vehiculization of Diclofenac.
http://www.mab4.uns.edu.ar/desc2.php?arc=014.pdf

[29]   Volonté, M.G. and Quiroga, P. (2013) Pharmaceutical Analysis. Editorial of the University of La Plata. 1-27.
http://sedici.unlp.edu.ar/bitstream/handle/10915/32503/Documento_completo.pdf?sequence=3

[30]   Hills, S., et al. (1992) An Investigation of the Pharmacokinetics of Topical Terbinafine. British Journal of Dermatology, 127, 322-326.
https://doi.org/10.1111/j.1365-2133.1992.tb00461.x

[31]   Walters, K.A. and Roberts, M.S. (2002) The Structure and Function of Skin. Marcel Dekker, New York, 1-40.

 
 
Top